Overcoming poor oral bioavailability using nanoparticle formulations - Opportunities and limitations

199Citations
Citations of this article
320Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Oral delivery of drugs with poor aqueous solubility and poor enzymatic and/or metabolic stability is very challenging. However, the advent of nanotechnology has revolutionized the field of oral drug delivery. The review provides an overview of various nano-architectures such as nanosuspensions, lipid and polymeric nanocarriers, inorganic nanostructures and describes advantages and challenges associated with their efficient delivery. Among various nano-architectures, only nanosuspensions and spontaneously emulsifying systems have succeeded in reaching pharmaceutical market. © 2011 Elsevier Ltd. All rights reserved.

Cite

CITATION STYLE

APA

Desai, P. P., Date, A. A., & Patravale, V. B. (2012). Overcoming poor oral bioavailability using nanoparticle formulations - Opportunities and limitations. Drug Discovery Today: Technologies. Elsevier Ltd. https://doi.org/10.1016/j.ddtec.2011.12.001

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free